Top Biotech Earnings Reports to Watch This Week

By Chris Lange Updated Jan 11, 4:07PM EST · Published Oct 21, 10:15AM EDT

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Top Biotech Earnings Reports to Watch This Week — © nevodka / iStock

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week. While health care doesn’t seem to be anywhere near the topic of debate ahead of this election season, it has the potential to be hugely affected by whatever party takes power in the United States.

For the other notable earnings this week, check out the Dow Jones industrials earnings and other major earnings previews.

Note that the earnings and revenue estimates may change ahead of the formal reports, and some companies may reschedule reporting dates as well.

Biogen Inc. (NASDAQ: BIIB) is set to report its most recent results on Tuesday. The consensus estimates from Thomson Reuters call for earnings per share (EPS) of $6.78 and $3.33 billion in revenue. Shares were changing hands at $320.41 on Friday’s close. The 52-week range is $249.17 to $388.67.

[nativounit]

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) is scheduled to report its third-quarter results on Wednesday. The consensus estimates are $1.74 in EPS and $1.02 billion in revenue. Shares traded at $125.89 as last week came to a close. The consensus price target is $163.41, and the 52-week trading range is $102.10 to $142.24.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is set to share its latest quarterly earnings on Thursday. The consensus estimates call for a net loss of $0.21 per share on $366.93 million in revenue. Shares were at $103.22 on Friday’s close, in a 52-week range of $75.81 to $106.74. The consensus price target is $120.05.

Bristol-Myers Squibb Co. (NYSE: BMY) is expected to reveal its third-quarter results on Thursday. The consensus forecast calls for $0.91 in EPS, as well as $5.72 billion in revenue. The stock ended last week at $54.30 per share. The consensus price target is $61.59, and the 52-week range is $49.96 to $70.05.

Celgene Corp. (NASDAQ: CELG) also will share its latest quarterly earnings on Thursday. The consensus estimates call for $2.34 in EPS and $1.74 billion in revenue. Shares were at $99.62 as Friday’s trading ended, in a 52-week range of $95.45 to $119.29. The consensus price target is $128.22.

And Gilead Sciences Inc. (NASDAQ: GILD) is expected to reveal its third-quarter results on Thursday as well. The consensus forecast calls for $1.63 in EPS, as well as $5.37 billion in revenue. The stock ended last week at $73.27 per share. The consensus price target is $87.91, and the 52-week trading range is $64.27 to $89.54.

[recirclink id=499840]

[wallst_email_signup]

About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.